- Home
- YHGJ vs APTO Comparison
YHGJ vs APTO Comparison
Compare YHGJ & APTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YHGJ
- APTO
- Stock Information
- Founded
- YHGJ 1975
- APTO 1986
- Country
- YHGJ United States
- APTO Canada
- Employees
- YHGJ N/A
- APTO N/A
- Industry
- YHGJ Specialty Chemicals
- APTO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- YHGJ Industrials
- APTO Health Care
- Exchange
- YHGJ Nasdaq
- APTO Nasdaq
- Market Cap
- YHGJ 15.8M
- APTO 6.8M
- IPO Year
- YHGJ 1997
- APTO N/A
- Fundamental
- Price
- YHGJ $1.02
- APTO $3.78
- Analyst Decision
- YHGJ
- APTO Strong Buy
- Analyst Count
- YHGJ 0
- APTO 3
- Target Price
- YHGJ N/A
- APTO $130.00
- AVG Volume (30 Days)
- YHGJ 41.7K
- APTO 403.5K
- Earning Date
- YHGJ 03-21-2025
- APTO 03-25-2025
- Dividend Yield
- YHGJ N/A
- APTO N/A
- EPS Growth
- YHGJ N/A
- APTO N/A
- EPS
- YHGJ N/A
- APTO N/A
- Revenue
- YHGJ $18,559,000.00
- APTO N/A
- Revenue This Year
- YHGJ N/A
- APTO N/A
- Revenue Next Year
- YHGJ N/A
- APTO N/A
- P/E Ratio
- YHGJ N/A
- APTO N/A
- Revenue Growth
- YHGJ 11.78
- APTO N/A
- 52 Week Low
- YHGJ $0.43
- APTO $2.39
- 52 Week High
- YHGJ $1.85
- APTO $51.60
- Technical
- Relative Strength Index (RSI)
- YHGJ 78.94
- APTO 45.54
- Support Level
- YHGJ $0.58
- APTO $2.82
- Resistance Level
- YHGJ $0.69
- APTO $7.80
- Average True Range (ATR)
- YHGJ 0.08
- APTO 0.44
- MACD
- YHGJ 0.03
- APTO 0.09
- Stochastic Oscillator
- YHGJ 93.62
- APTO 57.68
About YHGJ Yunhong Green CTI Ltd.
Yunhong Green CTI Ltd manufactures and marketers of foil balloons and produces laminated and printed films for commercial uses. The company also distributes balloon-inspired and other gift items, and continues development of compostable material solutions, and markets its products throughout the United States and in several other countries.
About APTO Aptose Biosciences Inc.
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.